๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Peritoneal carcinomatosis from colorectal cancer: The need for improving selection criteria for cytoreductive surgery and intraperitoneal chemotherapy

โœ Scribed by Samuel Aguiar Jr


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
41 KB
Volume
102
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Results of cytoreductive surgery and hyp
โœ Gabriel Glockzin; Nabil Ghali; Sven A. Lang; Hans J. Schlitt; Pompiliu Piso ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 168 KB

## Abstract Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide a promising additional treatment option for selected patients with peritoneal carcinomatosis arising from colorectal cancer. Due to the aggressive surgery the concept is associated with a significa

Outcomes of elderly patients undergoing
โœ Yvonne L.B. Klaver; Terence C. Chua; Ignace H.J.T. de Hingh; David L. Morris ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 96 KB

## Abstract ## Background The combined treatment of cytoreductive surgery (CRS) and perioperative chemotherapy (PIC) for colorectal peritoneal carcinomatosis (PC) is a rigorous surgical treatment most suited for fit and young patients. With technical maturity and improved perioperative care, we ex

Cytoreductive surgery and intraperitonea
โœ Samuel P. Jacks; Jonathan C. Hundley; Perry Shen; Greg B. Russell; Edward A. Lev ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 79 KB

Introduction: Peritoneal carcinomatosis (PC) is associated with a dismal prognosis. Small bowel adenocarcinoma is a rare etiology for PC. Due to the rarity, poor prognosis, and lack of standard treatment, we chose to review our experience with this disease process treated with cytoreductive surgery

Intraperitoneal chemotherapy and cytored
โœ Paul H. Sugarbaker ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 47 KB ๐Ÿ‘ 1 views

Intraperitoneal chemotherapy and cytoreductive surgery have been combined to reach treatment objectives in patients with peritoneal carcinomatosis or sarcomatosis that neither modality by itself can achieve. These treatments must be combined with the proper selection of patients in order to observe